Can AI Save Pfizer Stock Before Its Patent Cliff Hits?
Management’s story has pivoted from concrete wins today to a distant, AI-powered future, a move that coincides with…
Can Cost Cuts And 2030 Targets Really Save Pfizer Stock?
The company now leads with a cost-savings total and a growth rate that does not begin until the…
Pfizer Stock Is A Race Between New Drugs And Old Patents
The medicines Pfizer has launched and acquired are arriving at close to the scale of the revenue its…
Is Pfizer Stock an Underrated Healthcare Investment Play?
Pharmaceutical giant Pfizer (NYSE: PFE) recently had to drop its internally developed GLP-1 weight loss drug candidate. The…